1. Home
  2. TFFP

as 06-21-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.

Founded: 2018 Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 6.3M IPO Year: 2019
Target Price: $44.00 AVG Volume (30 days): 39.1K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -9.75 EPS Growth: N/A
52 Week Low/High: $1.54 - $14.18 Next Earning Date: 08-12-2024
Revenue: $885,715 Revenue Growth: 84.60%
Revenue Growth (this year): -40.51% Revenue Growth (next year): -29.91%

TFFP Daily Stock ML Predictions

Share on Social Networks: